Nasal CPAP and surfactant for treatment of respiratory distress syndrome and prevention of bronchopulmonary dysplasia.

Verder, Henrik; Bohlin, Kajsa; Kamper, Jens; Lindwall, Robert; Jonsson, Baldvin

Verder, Henrik; Bohlin, Kajsa; Kamper, Jens; Lindwall, Robert; Jonsson, Baldvin.

Affiliation

Verder H; Department of Paediatrics, Holbaek University Hospital, University of Copenhagen, Holbaek, Denmark. hav@regionsjaelland.dk

Acta Paediatr ; 98(9): 1400-8, 2009 Sep.

Article in En | MEDLINE | ID: mdl-19572989

Subject(s)

Bronchopulmonary Dysplasia/prevention & control; Continuous Positive Airway Pressure/methods; Pulmonary Surfactants/therapeutic use; Respiratory Distress Syndrome, Newborn/therapy; Apnea/therapy; Caffeine/therapeutic use; Central Nervous System Stimulants/therapeutic use; Citrates/therapeutic use; Combined Modality Therapy; Continuous Positive Airway Pressure/instrumentation; Humans; Infant, Newborn; Positive-Pressure Respiration; Respiration, Artificial/adverse effects

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Respiratory Distress Syndrome, Newborn / Pulmonary Surfactants / Bronchopulmonary Dysplasia / Continuous Positive Airway Pressure Limits: Humans / Newborn Language: En Journal: Acta Paediatr Year: 2009 Document type: Article Affiliation country: Denmark Country of publication: Norway

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google